USANA Health Sciences, Inc. (USNA) |
| 20.06 1 (5.25%) 04-17 16:00 |
| Open: | 19.38 |
| High: | 20.24 |
| Low: | 19.2796 |
| Volume: | 127,105 |
| Market Cap: | 370(M) |
| PE Ratio: | 34.59 |
| Exchange: | New York Stock Exchange |
| Industry: | Packaged Foods |
| Sector: | Consumer Defensive |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 23.64 |
| Resistance 1: | 20.24 |
| Pivot price: | 18.03 |
| Support 1: | 17.99 |
| Support 2: | 16.60 |
| 52w High: | 38.32 |
| 52w Low: | 16.6 |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
| EPS | 0.580 |
| Book Value | 29.160 |
| PEG Ratio | 0.00 |
| Gross Profit | 39.242 |
| Profit Margin (%) | 1.16 |
| Operating Margin (%) | 7.63 |
| Return on Assets (ttm) | 4.3 |
| Return on Equity (ttm) | 2.0 |
Wed, 15 Apr 2026
USANA Health Sciences (NYSE:USNA) Raised to "Strong-Buy" at Zacks Research - MarketBeat
Wed, 15 Apr 2026
USANA Schedules First Quarter 2026 Earnings Release and Conference Call - Business Wire
Wed, 15 Apr 2026
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates - Eastern Progress
Tue, 14 Apr 2026
USNA vs. SDZNY: Which Stock Is the Better Value Option? - qz.com
Tue, 07 Apr 2026
[ARS] USANA HEALTH SCIENCES INC SEC Filing - Stock Titan
Wed, 01 Apr 2026
USANA Health (USNA) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Eastern Progress
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |